marketcaparena
Search

    ELAN

    Elanco Animal Health Inc

    Company overview

    Market capitalization
    $11.22B
    Employees
    9,400
    Latest publication
    2026-09-29
    About Elanco Animal Health Inc

    Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio Family, Interceptor Plus, Drontal family, and Drontal Plus; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark. It also provides farm animal products that help farmers improve animal health and wellbeing, and raise livestock, such as cattle, swine, and poultry. In addition, the company offers medicated feed additives, injectable antibiotics, vaccines, insecticides and enzymes, and others under the Rumensin, Baytril, and Experior trademarks for cattle; and under the Maxiban and Monteban trademarks for the control and prevention of intestinal disease in poultry. Further, it offers other pet health products for cats and dogs under the Atopica, Milbemax, Onsior, and Tru Family trademarks; and other farm animal products for poultry, cattle, and swine under the AviPro, Catosal, Denagard, Hemicell, Pulmotil, and Surmax tradmarks. The company sells its products to third-party distributors and independent retailers; and directly to farm animal producers and veterinarians. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Indianapolis, Indiana.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue1,368,000,000USD1,371,000,000USD1,144,000,000USD1,137,000,000USD1,241,000,000USD1,193,000,000USD1,020,000,000USD1,030,000,000USD
    Cost Of Revenue570,000,000USD586,000,000USD694,000,000USD530,000,000USD664,000,000USD637,000,000USD631,000,000USD625,000,000USD
    Gross Profit798,000,000USD785,000,000USD450,000,000USD607,000,000USD577,000,000USD556,000,000USD389,000,000USD405,000,000USD
    Research Development92,000,000USD97,000,000USD93,000,000USD89,000,000USD92,000,000USD94,000,000USD81,000,000USD87,000,000USD
    Selling General Administrative449,000,000USD381,000,000USD338,000,000USD351,000,000USD400,000,000USD341,000,000USD300,000,000USD323,000,000USD
    Other Operating Expenses9,000,000USD———————
    Total Operating Expenses550,000,000USD478,000,000USD431,000,000USD580,000,000USD492,000,000USD435,000,000USD381,000,000USD410,000,000USD
    Operating Income248,000,000USD307,000,000USD19,000,000USD27,000,000USD85,000,000USD121,000,000USD8,000,000USD-5,000,000USD
    Total Other Income Expense Net-192,000,000USD-220,000,000USD-278,000,000USD-77,000,000USD-60,000,000USD-61,000,000USD-59,000,000USD564,000,000USD
    Interest Expense59,000,000USD57,000,000USD91,000,000USD52,000,000USD70,000,000USD53,000,000USD62,000,000USD85,000,000USD
    Income Before Tax56,000,000USD87,000,000USD-259,000,000USD-50,000,000USD25,000,000USD60,000,000USD-51,000,000USD559,000,000USD
    Income Tax Expense2,000,000USD30,000,000USD17,000,000USD-16,000,000USD14,000,000USD-7,000,000USD-43,000,000USD195,000,000USD
    Net Income54,000,000USD57,000,000USD-276,000,000USD-34,000,000USD11,000,000USD67,000,000USD-8,000,000USD364,000,000USD
    Net Interest Income—-57,000,000USD-80,000,000USD-52,000,000USD-48,000,000USD-40,000,000USD-46,000,000USD-58,000,000USD
    Tax Provision—30,000,000USD17,000,000USD-16,000,000USD14,000,000USD-7,000,000USD-43,000,000USD195,000,000USD
    Net Income From Continuing Ops—57,000,000USD-276,000,000USD-34,000,000USD11,000,000USD67,000,000USD-8,000,000USD364,000,000USD
    Ebit—144,000,000USD-168,000,000USD2,000,000USD95,000,000USD113,000,000USD11,000,000USD644,000,000USD
    Ebitda—316,000,000USD6,000,000USD178,000,000USD264,000,000USD274,000,000USD175,000,000USD814,000,000USD
    Depreciation And Amortization—172,000,000USD174,000,000USD176,000,000USD169,000,000USD161,000,000USD164,000,000USD170,000,000USD
    Reconciled Depreciation—172,000,000USD174,000,000USD176,000,000USD169,000,000USD161,000,000USD164,000,000USD170,000,000USD
    Unclassified Operating Expenses———140,000,000USD————
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USD
    Total Revenue4,715,000,000USD4,439,000,000USD4,417,000,000USD4,411,000,000USD4,764,000,000USD3,071,000,000USD3,066,800,000USD2,889,000,000USD
    Cost Of Revenue2,665,000,000USD2,530,000,000USD2,479,000,000USD2,441,000,000USD2,688,000,000USD1,670,700,000USD1,771,200,000USD1,715,100,000USD
    Gross Profit2,050,000,000USD1,909,000,000USD1,938,000,000USD1,970,000,000USD2,076,000,000USD1,400,300,000USD1,295,600,000USD1,173,900,000USD
    Research Development368,000,000USD344,000,000USD327,000,000USD321,000,000USD369,000,000USD270,100,000USD246,600,000USD251,700,000USD
    Selling General Administrative1,430,000,000USD1,072,000,000USD1,073,000,000USD1,065,000,000USD1,156,000,000USD760,200,000USD735,200,000USD779,800,000USD
    Total Operating Expenses1,798,000,000USD1,658,000,000USD1,612,000,000USD1,586,000,000USD1,772,000,000USD1,030,300,000USD981,800,000USD1,031,500,000USD
    Operating Income252,000,000USD251,000,000USD326,000,000USD384,000,000USD304,000,000USD370,000,000USD313,800,000USD142,400,000USD
    Interest Expense220,000,000USD339,000,000USD277,000,000USD256,000,000USD264,000,000USD78,900,000USD29,600,000USD0USD
    Net Interest Income-220,000,000USD-235,000,000USD-272,000,000USD-241,000,000USD-236,000,000USD-78,900,000USD-29,600,000USD—
    Income Before Tax-224,000,000USD488,000,000USD-1,195,000,000USD-72,000,000USD-571,000,000USD78,200,000USD114,100,000USD-232,600,000USD
    Income Tax Expense8,000,000USD150,000,000USD36,000,000USD6,000,000USD-88,000,000USD10,300,000USD27,600,000USD78,100,000USD
    Tax Provision8,000,000USD150,000,000USD-13,000,000USD8,000,000USD-95,000,000USD10,300,000USD27,600,000USD78,100,000USD
    Net Income-232,000,000USD338,000,000USD-1,231,000,000USD-78,000,000USD-483,000,000USD67,900,000USD86,500,000USD-310,700,000USD
    Net Income From Continuing Ops-232,000,000USD338,000,000USD-1,144,000,000USD-74,000,000USD-472,000,000USD67,900,000USD86,500,000USD-310,700,000USD
    Ebit-4,000,000USD827,000,000USD-918,000,000USD184,000,000USD-307,000,000USD157,100,000USD143,700,000USD-232,600,000USD
    Ebitda676,000,000USD1,489,000,000USD-224,000,000USD866,000,000USD409,000,000USD471,600,000USD439,700,000USD85,800,000USD
    Depreciation And Amortization680,000,000USD662,000,000USD694,000,000USD682,000,000USD716,000,000USD314,500,000USD296,000,000USD318,400,000USD
    Reconciled Depreciation680,000,000USD662,000,000USD691,000,000USD528,000,000USD556,000,000USD314,500,000USD296,000,000USD318,400,000USD
    Total Other Income Expense Net-476,000,000USD237,000,000USD-1,521,000,000USD-456,000,000USD-875,000,000USD-291,800,000USD-199,700,000USD-375,000,000USD
    Selling And Marketing Expenses—236,000,000USD207,000,000USD201,000,000USD248,000,000USD———
    Non Operating Income Net Other———-32,000,000USD-5,000,000USD-27,400,000USD-41,300,000USD—
    Net Income Applicable To Common Shares———-78,000,000USD-472,000,000USD67,900,000USD86,500,000USD-310,700,000USD
    Interest Income—————78,900,000USD29,600,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets13,561,000,000USD13,222,000,000USD13,358,000,000USD13,551,000,000USD13,742,000,000USD12,941,000,000USD12,614,000,000USD13,283,000,000USD
    Cash And Equivalents530,000,000USD———————
    Total Current Assets3,797,000,000USD3,584,000,000USD3,458,000,000USD3,493,000,000USD3,614,000,000USD3,440,000,000USD3,215,000,000USD3,366,000,000USD
    Other Current Assets346,000,000USD285,000,000USD236,000,000USD305,000,000USD302,000,000USD301,000,000USD287,000,000USD340,000,000USD
    Other Non Current Assets304,000,000USD———————
    Total Liabilities6,973,000,000USD———————
    Total Current Liabilities1,852,000,000USD1,662,000,000USD1,597,000,000USD1,455,000,000USD1,392,000,000USD1,269,000,000USD1,315,000,000USD1,321,000,000USD
    Other Current Liabilities902,000,000USD———————
    Other Non Current Liabilities551,000,000USD———————
    Total Stockholder Equity6,588,000,000USD6,500,000,000USD6,547,000,000USD6,749,000,000USD6,775,000,000USD6,353,000,000USD6,096,000,000USD6,523,000,000USD
    Total Equity Including Noncontrolling Interest6,588,000,000USD———————
    Long Term Debt3,845,000,000USD3,918,000,000USD3,943,000,000USD3,962,000,000USD4,148,000,000USD4,351,000,000USD4,277,000,000USD4,313,000,000USD
    Deferred Revenue450,000,000USD———————
    Net Receivables1,077,000,000USD1,154,000,000USD940,000,000USD975,000,000USD1,103,000,000USD1,060,000,000USD886,000,000USD904,000,000USD
    Inventory1,769,000,000USD1,717,000,000USD1,737,000,000USD1,708,000,000USD1,670,000,000USD1,592,000,000USD1,574,000,000USD1,632,000,000USD
    Property Plant Equipment Net1,411,000,000USD1,395,000,000USD1,409,000,000USD1,392,000,000USD1,357,000,000USD1,047,000,000USD993,000,000USD979,000,000USD
    Goodwill4,845,000,000USD———————
    Intangible Assets3,204,000,000USD3,225,000,000USD3,408,000,000USD3,596,000,000USD3,705,000,000USD3,634,000,000USD3,681,000,000USD4,011,000,000USD
    Accounts Payable427,000,000USD372,000,000USD368,000,000USD352,000,000USD368,000,000USD330,000,000USD296,000,000USD259,000,000USD
    Common Stock0USD———————
    Retained Earnings-2,071,000,000USD-2,125,000,000USD-2,182,000,000USD-1,906,000,000USD-1,872,000,000USD-1,883,000,000USD-1,950,000,000USD-1,942,000,000USD
    Accumulated Other Comprehensive Income-219,000,000USD-233,000,000USD-141,000,000USD-199,000,000USD-192,000,000USD-583,000,000USD-771,000,000USD-339,000,000USD
    Total Liab—6,722,000,000USD6,811,000,000USD6,802,000,000USD6,967,000,000USD6,588,000,000USD6,518,000,000USD6,760,000,000USD
    Other Current Liab—1,217,000,000USD1,155,000,000USD1,041,000,000USD963,000,000USD895,000,000USD975,000,000USD1,018,000,000USD
    Capital Stock—0USD0USD0USD0USD0USD0USD0USD
    Good Will—4,723,000,000USD4,779,000,000USD4,764,000,000USD4,758,000,000USD4,508,000,000USD4,414,000,000USD4,625,000,000USD
    Cash—428,000,000USD545,000,000USD505,000,000USD539,000,000USD487,000,000USD468,000,000USD490,000,000USD
    Cash And Short Term Investments—428,000,000USD545,000,000USD505,000,000USD539,000,000USD487,000,000USD468,000,000USD490,000,000USD
    Net Debt—3,563,000,000USD3,472,000,000USD3,519,000,000USD3,670,000,000USD3,908,000,000USD3,853,000,000USD3,867,000,000USD
    Short Term Debt—73,000,000USD74,000,000USD62,000,000USD61,000,000USD44,000,000USD44,000,000USD44,000,000USD
    Short Long Term Debt—73,000,000USD74,000,000USD62,000,000USD61,000,000USD44,000,000USD44,000,000USD44,000,000USD
    Short Long Term Debt Total—3,991,000,000USD4,017,000,000USD4,024,000,000USD4,209,000,000USD4,395,000,000USD4,321,000,000USD4,357,000,000USD
    Common Stock Shares Outstanding—506,000,000shares496,900,000shares496,800,000shares500,100,000shares499,100,000shares494,400,000shares497,700,000shares
    Non Current Assets Total—9,638,000,000USD9,900,000,000USD10,058,000,000USD10,128,000,000USD9,501,000,000USD9,399,000,000USD9,917,000,000USD
    Non Current Liabilities Total—5,060,000,000USD5,214,000,000USD5,347,000,000USD5,575,000,000USD5,319,000,000USD5,203,000,000USD5,439,000,000USD
    Non Current Liabilities Other—467,000,000USD427,000,000USD607,000,000USD638,000,000USD487,000,000USD302,000,000USD587,000,000USD
    Non Currrent Assets Other—295,000,000USD304,000,000USD306,000,000USD294,000,000USD312,000,000USD311,000,000USD302,000,000USD
    Net Working Capital—1,922,000,000USD1,861,000,000USD2,038,000,000USD2,222,000,000USD2,171,000,000USD1,900,000,000USD2,045,000,000USD
    Unclassified Current Liabilities—-73,000,000USD-74,000,000USD-62,000,000USD-61,000,000USD-44,000,000USD-44,000,000USD-44,000,000USD
    Unclassified Non Current Liabilities—675,000,000USD844,000,000USD778,000,000USD789,000,000USD481,000,000USD624,000,000USD539,000,000USD
    Unclassified Equity—8,858,000,000USD8,870,000,000USD8,854,000,000USD8,839,000,000USD8,819,000,000USD8,817,000,000USD8,804,000,000USD
    Property Plant Equipment Gross——2,361,000,000USD———1,851,000,000USD—
    Other Assets——————9,397,940,000USD—
    Unclassified Non Current Assets——————-9,397,940,000USD—
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets13,358,000,000USD12,614,000,000USD14,362,000,000USD15,491,000,000USD16,478,000,000USD17,693,000,000USD8,985,800,000USD8,956,700,000USD
    Intangible Assets3,408,000,000USD3,681,000,000USD4,494,000,000USD4,842,000,000USD5,587,000,000USD6,387,000,000USD2,482,800,000USD2,453,000,000USD
    Other Current Assets236,000,000USD287,000,000USD310,000,000USD394,000,000USD237,000,000USD267,000,000USD98,500,000USD316,600,000USD
    Total Liab6,811,000,000USD6,518,000,000USD8,139,000,000USD8,202,000,000USD8,970,000,000USD9,217,000,000USD3,438,900,000USD3,759,200,000USD
    Total Stockholder Equity6,547,000,000USD6,096,000,000USD6,223,000,000USD7,289,000,000USD7,508,000,000USD8,476,000,000USD5,546,900,000USD5,197,500,000USD
    Other Current Liab1,155,000,000USD975,000,000USD933,000,000USD924,000,000USD937,000,000USD1,021,000,000USD571,400,000USD736,500,000USD
    Capital Stock0USD0USD0USD0USD0USD0USD0USD0USD
    Retained Earnings-2,182,000,000USD-1,950,000,000USD-2,288,000,000USD-1,057,000,000USD-979,000,000USD-477,000,000USD84,300,000USD16,400,000USD
    Good Will4,779,000,000USD4,414,000,000USD5,094,000,000USD5,993,000,000USD6,172,000,000USD6,225,000,000USD2,989,600,000USD2,958,000,000USD
    Cash545,000,000USD468,000,000USD352,000,000USD345,000,000USD638,000,000USD495,000,000USD334,000,000USD474,800,000USD
    Cash And Short Term Investments545,000,000USD468,000,000USD352,000,000USD345,000,000USD638,000,000USD495,000,000USD334,000,000USD474,800,000USD
    Total Current Assets3,458,000,000USD3,215,000,000USD3,407,000,000USD3,279,000,000USD3,274,000,000USD3,417,000,000USD2,373,100,000USD2,504,900,000USD
    Total Current Liabilities1,597,000,000USD1,315,000,000USD1,241,000,000USD1,702,000,000USD1,647,000,000USD2,077,000,000USD818,500,000USD970,700,000USD
    Net Debt3,472,000,000USD3,853,000,000USD5,422,000,000USD5,491,000,000USD5,681,000,000USD5,632,000,000USD2,021,000,000USD1,997,500,000USD
    Short Term Debt74,000,000USD44,000,000USD38,000,000USD388,000,000USD294,000,000USD555,000,000USD24,500,000USD29,000,000USD
    Short Long Term Debt74,000,000USD44,000,000USD38,000,000USD388,000,000USD294,000,000USD554,500,000USD24,500,000USD29,000,000USD
    Short Long Term Debt Total4,017,000,000USD4,321,000,000USD5,774,000,000USD5,836,000,000USD6,319,000,000USD6,127,000,000USD2,355,000,000USD2,472,300,000USD
    Long Term Debt3,943,000,000USD4,277,000,000USD5,736,000,000USD5,448,000,000USD6,025,000,000USD5,572,400,000USD2,330,500,000USD2,443,300,000USD
    Net Receivables940,000,000USD886,000,000USD1,010,000,000USD1,002,000,000USD1,028,000,000USD1,077,000,000USD889,900,000USD709,400,000USD
    Inventory1,737,000,000USD1,574,000,000USD1,735,000,000USD1,538,000,000USD1,371,000,000USD1,578,000,000USD1,050,700,000USD1,004,100,000USD
    Accounts Payable368,000,000USD296,000,000USD270,000,000USD390,000,000USD416,000,000USD501,000,000USD222,600,000USD205,200,000USD
    Property Plant Equipment Net1,409,000,000USD993,000,000USD1,026,000,000USD999,000,000USD1,055,000,000USD1,316,000,000USD955,300,000USD922,400,000USD
    Property Plant Equipment Gross2,361,000,000USD1,851,000,000USD1,841,000,000USD1,722,000,000USD2,102,000,000USD1,316,300,000USD955,300,000USD922,400,000USD
    Accumulated Other Comprehensive Income-141,000,000USD-771,000,000USD-266,000,000USD-392,000,000USD-209,000,000USD303,000,000USD-173,700,000USD-222,200,000USD
    Common Stock Shares Outstanding496,400,000shares497,300,000shares492,300,000shares488,300,000shares487,200,000shares441,400,000shares370,300,000shares313,700,000shares
    Non Current Assets Total9,900,000,000USD9,399,000,000USD10,955,000,000USD12,212,000,000USD13,204,000,000USD14,276,000,000USD6,612,700,000USD6,451,800,000USD
    Non Current Liabilities Total5,214,000,000USD5,203,000,000USD6,898,000,000USD6,500,000,000USD7,323,000,000USD7,140,000,000USD2,620,400,000USD2,788,500,000USD
    Non Current Liabilities Other427,000,000USD302,000,000USD411,000,000USD229,000,000USD261,000,000USD322,100,000USD106,600,000USD121,500,000USD
    Non Currrent Assets Other304,000,000USD311,000,000USD341,000,000USD378,000,000USD390,000,000USD348,000,000USD185,000,000USD103,100,000USD
    Net Working Capital1,861,000,000USD1,900,000,000USD2,166,000,000USD1,577,000,000USD1,633,000,000USD1,340,200,000USD1,554,600,000USD1,534,200,000USD
    Unclassified Current Liabilities-74,000,000USD-44,000,000USD-562,000,000USD-388,000,000USD-479,000,000USD-703,100,000USD-140,500,000USD-396,600,000USD
    Unclassified Non Current Liabilities844,000,000USD624,000,000USD751,000,000USD-118,000,000USD-113,000,000USD-95,400,000USD-44,900,000USD-114,100,000USD
    Unclassified Equity8,870,000,000USD8,817,000,000USD8,777,000,000USD8,738,000,000USD8,696,000,000USD8,650,000,000USD5,636,300,000USD5,403,300,000USD
    Current Deferred Revenue——524,000,000USD—185,000,000USD148,600,000USD116,000,000USD367,600,000USD
    Other Liab———941,000,000USD1,150,000,000USD1,340,900,000USD228,200,000USD337,800,000USD
    Other Assets———193,000,000USD183,000,000USD127,300,000USD78,900,000USD51,300,000USD
    Short Term Investments———14,000,000USD————
    Net Tangible Assets———-3,546,000,000USD-4,325,000,000USD-4,136,200,000USD74,500,000USD-265,300,000USD
    Unclassified Non Current Assets———-193,000,000USD-183,000,000USD—-100,000,000USD—
    Long Term Investments——————21,100,000USD15,300,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation343,000,000USD
    Stock Based Compensation41,000,000USD
    Operating Cash Flow290,000,000USD
    Capital Expenditures-84,000,000USD
    Other Investing Activities-66,000,000USD
    Unclassified Investing Cash Flow-20,000,000USD
    Investing Cash Flow-170,000,000USD
    Net Common Stock Issuance-35,000,000USD
    Other Financing Activities-15,000,000USD
    Unclassified Financing Cash Flow-89,000,000USD
    Financing Cash Flow-139,000,000USD
    Effect Of Forex Changes On Cash4,000,000USD
    Change In Cash-15,000,000USD
    End Cash Flow530,000,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USDQ1 20242024-03-31 · USD
    Net Income57,000,000USD-34,000,000USD11,000,000USD67,000,000USD-8,000,000USD364,000,000USD-50,000,000USD32,000,000USD
    Depreciation172,000,000USD176,000,000USD169,000,000USD161,000,000USD164,000,000USD170,000,000USD162,000,000USD166,000,000USD
    Stock Based Compensation21,000,000USD17,000,000USD20,000,000USD15,000,000USD15,000,000USD15,000,000USD14,000,000USD11,000,000USD
    Other Non Cash Items26,000,000USD297,000,000USD-15,000,000USD-10,000,000USD32,000,000USD-542,000,000USD52,000,000USD-30,000,000USD
    Change In Working Capital-263,000,000USD-237,000,000USD52,000,000USD-237,000,000USD-26,000,000USD155,000,000USD22,000,000USD-177,000,000USD
    Total Cash From Operating Activities13,000,000USD219,000,000USD237,000,000USD-4,000,000USD177,000,000USD162,000,000USD200,000,000USD2,000,000USD
    Capital Expenditures-51,000,000USD-92,000,000USD-57,000,000USD-65,000,000USD-53,000,000USD-42,000,000USD-34,000,000USD-24,000,000USD
    Free Cash Flow-38,000,000USD127,000,000USD180,000,000USD-69,000,000USD124,000,000USD120,000,000USD166,000,000USD-22,000,000USD
    Total Cashflows From Investing Activities-60,000,000USD-101,000,000USD-56,000,000USD-58,000,000USD-90,000,000USD1,244,000,000USD-33,000,000USD37,000,000USD
    Net Borrowings-16,000,000USD-188,000,000USD-446,000,000USD72,000,000USD-38,000,000USD-1,332,000,000USD——
    Total Cash From Financing Activities-65,000,000USD-153,000,000USD-156,000,000USD52,000,000USD-32,000,000USD-1,340,000,000USD-93,000,000USD-27,000,000USD
    Sale Purchase Of Stock-34,000,000USD——-13,000,000USD————
    Change In Cash-117,000,000USD-34,000,000USD52,000,000USD19,000,000USD-22,000,000USD74,000,000USD71,000,000USD-7,000,000USD
    Begin Period Cash Flow545,000,000USD539,000,000USD487,000,000USD468,000,000USD490,000,000USD416,000,000USD345,000,000USD352,000,000USD
    End Period Cash Flow428,000,000USD505,000,000USD539,000,000USD487,000,000USD468,000,000USD490,000,000USD416,000,000USD345,000,000USD
    Other Cashflows From Investing Activities-9,000,000USD-16,000,000USD8,000,000USD-2,000,000USD-7,000,000USD1,281,000,000USD1,000,000USD66,000,000USD
    Other Cashflows From Financing Activities-15,000,000USD-255,000,000USD290,000,000USD-20,000,000USD6,000,000USD-8,000,000USD-1,000,000USD-14,000,000USD
    Investments—-101,000,000USD-56,000,000USD-58,000,000USD-90,000,000USD1,244,000,000USD-33,000,000USD37,000,000USD
    Unclassified Investing Cash Flow—108,000,000USD49,000,000USD67,000,000USD60,000,000USD-1,239,000,000USD33,000,000USD-42,000,000USD
    Unclassified Financing Cash Flow—290,000,000USD—13,000,000USD——-92,000,000USD-13,000,000USD
    Change To Account Receivables————12,000,000USD———
    Change To Inventory————44,000,000USD———
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USD
    Net Income-232,000,000USD338,000,000USD-1,231,000,000USD-78,000,000USD-574,000,000USD67,900,000USD86,500,000USD-310,700,000USD
    Depreciation680,000,000USD662,000,000USD694,000,000USD682,000,000USD517,000,000USD314,500,000USD296,000,000USD318,400,000USD
    Stock Based Compensation68,000,000USD55,000,000USD46,000,000USD59,000,000USD47,000,000USD49,400,000USD26,000,000USD25,000,000USD
    Other Non Cash Items79,000,000USD-551,000,000USD1,142,000,000USD308,000,000USD-86,000,000USD19,900,000USD168,700,000USD101,000,000USD
    Change To Account Receivables-12,000,000USD12,000,000USD-40,000,000USD14,000,000USD24,000,000USD-172,400,000USD-122,000,000USD48,400,000USD
    Change To Inventory-57,000,000USD44,000,000USD-160,000,000USD-269,000,000USD-95,000,000USD-33,100,000USD-20,100,000USD-39,000,000USD
    Change In Working Capital99,000,000USD149,000,000USD-300,000,000USD-462,000,000USD169,000,000USD-227,700,000USD-29,200,000USD53,500,000USD
    Total Cash From Operating Activities560,000,000USD541,000,000USD271,000,000USD452,000,000USD-41,000,000USD224,100,000USD487,300,000USD173,800,000USD
    Capital Expenditures-276,000,000USD-147,000,000USD-154,000,000USD-184,000,000USD-310,900,000USD-197,400,000USD-134,500,000USD-98,600,000USD
    Free Cash Flow284,000,000USD394,000,000USD117,000,000USD268,000,000USD-351,900,000USD26,700,000USD352,800,000USD75,200,000USD
    Total Cashflows From Investing Activities-279,000,000USD1,158,000,000USD-169,000,000USD-179,000,000USD-4,779,200,000USD-234,800,000USD-127,000,000USD-964,600,000USD
    Net Borrowings-563,000,000USD-1,475,000,000USD-77,000,000USD-518,000,000USD3,750,200,000USD-121,100,000USD2,468,000,000USD2,492,500,000USD
    Total Cash From Financing Activities-275,000,000USD-1,492,000,000USD-83,000,000USD-549,000,000USD4,953,900,000USD-304,800,000USD-35,200,000USD847,500,000USD
    Change In Cash77,000,000USD116,000,000USD7,000,000USD-293,000,000USD160,300,000USD-332,400,000USD354,100,000USD64,600,000USD
    Begin Period Cash Flow468,000,000USD352,000,000USD345,000,000USD638,000,000USD345,100,000USD677,500,000USD323,400,000USD258,800,000USD
    End Period Cash Flow545,000,000USD468,000,000USD352,000,000USD345,000,000USD505,400,000USD345,100,000USD677,500,000USD323,400,000USD
    Other Cashflows From Investing Activities-3,000,000USD-14,000,000USD-10,000,000USD-8,000,000USD169,200,000USD-4,600,000USD-1,900,000USD16,100,000USD
    Other Cashflows From Financing Activities288,000,000USD-17,000,000USD-6,000,000USD-32,000,000USD-118,100,000USD-183,800,000USD-4,187,400,000USD847,500,000USD
    Unclassified Operating Cash Flow-134,000,000USD-112,000,000USD-80,000,000USD-57,000,000USD-114,000,000USD—-60,700,000USD-13,400,000USD
    Investments—1,158,000,000USD-210,000,000USD-179,000,000USD32,700,000USD-234,800,000USD-127,000,000USD-964,600,000USD
    Unclassified Investing Cash Flow—161,000,000USD205,000,000USD192,000,000USD-4,670,200,000USD202,000,000USD136,400,000USD82,500,000USD
    Change To Liabilities———-98,000,000USD369,300,000USD-29,200,000USD116,100,000USD-8,400,000USD
    Issuance Of Capital Stock———0USD1,219,900,000USD1,219,900,000USD1,659,700,000USD—
    Cash And Cash Equivalents Changes———-276,000,000USD133,700,000USD-315,500,000USD325,100,000USD—
    Sale Purchase Of Stock————1,219,900,000USD—1,659,700,000USD—
    Unclassified Financing Cash Flow————101,900,000USD-1,219,800,000USD24,500,000USD-2,492,500,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30GeographyInternational705,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30GeographyUnited States663,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductContract Manufacturing17,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductFarm Animal — Cattle313,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductFarm Animal — Poultry223,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductFarm Animal — Swine97,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductPet Health718,000,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31GeographyInternational766,000,000USD0001739104-26-000030
    Q1 2026Quarterly · 2026-03-31GeographyUnited States605,000,000USD0001739104-26-000030
    Q1 2026Quarterly · 2026-03-31ProductContract Manufacturing19,000,000USD0001739104-26-000030
    Q1 2026Quarterly · 2026-03-31ProductFarm Animal — Cattle316,000,000USD0001739104-26-000030
    Q1 2026Quarterly · 2026-03-31ProductFarm Animal — Poultry230,000,000USD0001739104-26-000030
    Q1 2026Quarterly · 2026-03-31ProductFarm Animal — Swine96,000,000USD0001739104-26-000030
    Q1 2026Quarterly · 2026-03-31ProductPet Health710,000,000USD0001739104-26-000030
    Q4 2025Quarterly · 2025-12-31GeographyInternational604,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31GeographyUnited States540,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductAqua0USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductContract Manufacturing15,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductFarm Animal — Cattle296,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductFarm Animal — Poultry237,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductFarm Animal — Swine107,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductPet Health489,000,000USDLegacy provider
    FY 2025Yearly · 2025-12-31GeographyInternational2,481,000,000USD0001739104-26-000012
    FY 2025Yearly · 2025-12-31GeographyUnited States2,234,000,000USD0001739104-26-000012
    FY 2025Yearly · 2025-12-31ProductAqua0USD0001739104-26-000012
    FY 2025Yearly · 2025-12-31ProductContract Manufacturing53,000,000USD0001739104-26-000012
    FY 2025Yearly · 2025-12-31ProductFarm Animal — Cattle1,125,000,000USD0001739104-26-000012
    FY 2025Yearly · 2025-12-31ProductFarm Animal — Poultry858,000,000USD0001739104-26-000012
    FY 2025Yearly · 2025-12-31ProductFarm Animal — Swine379,000,000USD0001739104-26-000012
    FY 2025Yearly · 2025-12-31ProductPet Health2,300,000,000USD0001739104-26-000012
    Q3 2025Quarterly · 2025-09-30GeographyInternational590,000,000USD0001739104-25-000071
    Q3 2025Quarterly · 2025-09-30GeographyUnited States547,000,000USD0001739104-25-000071
    Q3 2025Quarterly · 2025-09-30ProductAqua0USD0001739104-25-000071
    Q3 2025Quarterly · 2025-09-30ProductContract Manufacturing11,000,000USD0001739104-25-000071
    Q3 2025Quarterly · 2025-09-30ProductFarm Animal — Cattle289,000,000USD0001739104-25-000071
    Q3 2025Quarterly · 2025-09-30ProductFarm Animal — Poultry217,000,000USD0001739104-25-000071
    Q3 2025Quarterly · 2025-09-30ProductFarm Animal — Swine87,000,000USD0001739104-25-000071
    Q3 2025Quarterly · 2025-09-30ProductPet Health533,000,000USD0001739104-25-000071
    Q2 2025Quarterly · 2025-06-30GeographyInternational648,000,000USD0001739104-25-000055
    Q2 2025Quarterly · 2025-06-30GeographyUnited States593,000,000USD0001739104-25-000055
    Q2 2025Quarterly · 2025-06-30ProductAqua0USD0001739104-25-000055
    Q2 2025Quarterly · 2025-06-30ProductContract Manufacturing15,000,000USD0001739104-25-000055
    Q2 2025Quarterly · 2025-06-30ProductFarm Animal — Cattle268,000,000USD0001739104-25-000055
    Q2 2025Quarterly · 2025-06-30ProductFarm Animal — Poultry215,000,000USD0001739104-25-000055
    Q2 2025Quarterly · 2025-06-30ProductFarm Animal — Swine100,000,000USD0001739104-25-000055
    Q2 2025Quarterly · 2025-06-30ProductPet Health643,000,000USD0001739104-25-000055
    Q1 2025Quarterly · 2025-03-31GeographyInternational639,000,000USD0001739104-26-000030
    Q1 2025Quarterly · 2025-03-31GeographyUnited States554,000,000USD0001739104-26-000030
    Q1 2025Quarterly · 2025-03-31ProductAqua0USD0001739104-25-000042
    Q1 2025Quarterly · 2025-03-31ProductContract Manufacturing12,000,000USD0001739104-25-000042
    Q1 2025Quarterly · 2025-03-31ProductFarm Animal — Cattle272,000,000USD0001739104-25-000042
    Q1 2025Quarterly · 2025-03-31ProductFarm Animal — Poultry189,000,000USD0001739104-25-000042
    Q1 2025Quarterly · 2025-03-31ProductFarm Animal — Swine85,000,000USD0001739104-25-000042
    Q1 2025Quarterly · 2025-03-31ProductPet Health635,000,000USD0001739104-25-000042
    Q4 2024Quarterly · 2024-12-31GeographyInternational545,000,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyUnited States475,000,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductContract Manufacturing11,000,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductFarm Animal — Aqua0USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductFarm Animal — Cattle253,000,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductFarm Animal — Poultry213,000,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductFarm Animal — Swine104,000,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductPet Health439,000,000USDLegacy provider
    FY 2024Yearly · 2024-12-31GeographyInternational2,403,000,000USD0001739104-26-000012
    FY 2024Yearly · 2024-12-31GeographyUnited States2,036,000,000USD0001739104-26-000012
    FY 2024Yearly · 2024-12-31ProductContract Manufacturing46,000,000USD0001739104-26-000012
    FY 2024Yearly · 2024-12-31ProductFarm Animal — Aqua81,000,000USD0001739104-26-000012
    FY 2024Yearly · 2024-12-31ProductFarm Animal — Cattle1,007,000,000USD0001739104-26-000012
    FY 2024Yearly · 2024-12-31ProductFarm Animal — Poultry796,000,000USD0001739104-26-000012
    FY 2024Yearly · 2024-12-31ProductFarm Animal — Swine366,000,000USD0001739104-26-000012
    FY 2024Yearly · 2024-12-31ProductPet Health2,143,000,000USD0001739104-26-000012
    Q3 2024Quarterly · 2024-09-30GeographyInternational543,000,000USD0001739104-25-000071
    Q3 2024Quarterly · 2024-09-30GeographyUnited States487,000,000USD0001739104-25-000071
    Q3 2024Quarterly · 2024-09-30ProductContract Manufacturing14,000,000USD0001739104-25-000071
    Q3 2024Quarterly · 2024-09-30ProductFarm Animal — Aqua1,000,000USD0001739104-25-000071
    Q3 2024Quarterly · 2024-09-30ProductFarm Animal — Cattle253,000,000USD0001739104-25-000071
    Q3 2024Quarterly · 2024-09-30ProductFarm Animal — Poultry188,000,000USD0001739104-25-000071
    Q3 2024Quarterly · 2024-09-30ProductFarm Animal — Swine88,000,000USD0001739104-25-000071
    Q3 2024Quarterly · 2024-09-30ProductPet Health486,000,000USD0001739104-25-000071
    FY 2023Yearly · 2023-12-31GeographyInternational2,434,000,000USD0001739104-26-000012
    FY 2023Yearly · 2023-12-31GeographyUnited States1,983,000,000USD0001739104-26-000012
    FY 2023Yearly · 2023-12-31ProductContract Manufacturing42,000,000USD0001739104-26-000012
    FY 2023Yearly · 2023-12-31ProductFarm Animal — Aqua175,000,000USD0001739104-26-000012
    FY 2023Yearly · 2023-12-31ProductFarm Animal — Cattle949,000,000USD0001739104-26-000012
    FY 2023Yearly · 2023-12-31ProductFarm Animal — Poultry765,000,000USD0001739104-26-000012
    FY 2023Yearly · 2023-12-31ProductFarm Animal — Swine382,000,000USD0001739104-26-000012
    FY 2023Yearly · 2023-12-31ProductPet Health2,104,000,000USD0001739104-26-000012
    FY 2022Yearly · 2022-12-31GeographyInternational2,446,000,000USD0001739104-25-000014
    FY 2022Yearly · 2022-12-31GeographyUnited States1,965,000,000USD0001739104-25-000014
    FY 2022Yearly · 2022-12-31ProductContract Manufacturing54,000,000USD0001739104-25-000014
    FY 2022Yearly · 2022-12-31ProductFarm Animal — Aqua175,000,000USD0001739104-25-000014
    FY 2022Yearly · 2022-12-31ProductFarm Animal — Cattle944,000,000USD0001739104-25-000014
    FY 2022Yearly · 2022-12-31ProductFarm Animal — Poultry716,000,000USD0001739104-25-000014
    FY 2022Yearly · 2022-12-31ProductFarm Animal — Swine384,000,000USD0001739104-25-000014
    FY 2022Yearly · 2022-12-31ProductPet Health2,138,000,000USD0001739104-25-000014
    FY 2021Yearly · 2021-12-31GeographyInternational2,640,000,000USD0001739104-24-000009
    FY 2021Yearly · 2021-12-31GeographyUnited States2,124,000,000USD0001739104-24-000009
    FY 2021Yearly · 2021-12-31ProductContract Manufacturing82,000,000USD0001739104-24-000009
    FY 2021Yearly · 2021-12-31ProductFarm Animal — Aqua144,000,000USD0001739104-24-000009
    FY 2021Yearly · 2021-12-31ProductFarm Animal — Cattle980,000,000USD0001739104-24-000009
    FY 2021Yearly · 2021-12-31ProductFarm Animal — Poultry744,000,000USD0001739104-24-000009

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.